LIPOPREDICT: Prediction of patients’ response to liposomal antineoplastic drugs: Focusing on the endocytic activity of LRP1B (Q2906914)

From EU Knowledge Graph
Revision as of 11:40, 14 September 2021 by DG Regio (talk | contribs) (‎Removed claim: co-financing rate (P837): 66.0 percent, Removing co-finance rate from projects in portugal)
Jump to navigation Jump to search
Project Q2906914 in Portugal
Language Label Description Also known as
English
LIPOPREDICT: Prediction of patients’ response to liposomal antineoplastic drugs: Focusing on the endocytic activity of LRP1B
Project Q2906914 in Portugal

    Statements

    0 references
    203,732.7 Euro
    0 references
    15 July 2018
    0 references
    14 July 2021
    0 references
    IPATIMUP-INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO
    0 references
    Q2993205 (Deleted Item)
    0 references

    41°8'58.02"N, 8°36'38.84"W
    0 references
    Porto
    0 references

    Identifiers

    POCI-01-0145-FEDER-031520
    0 references